Current pharmacological treatment of obsessive-compulsive disorder

Other Title(s)

العلاج الدوائي الحالي لاضطراب الوسواس القهري

Joint Authors

al-Tamimi, Sudad Jawad
Jamil, Nahlah Fawzi

Source

The Arab Journal of Psychiatry

Issue

Vol. 31, Issue 2 (30 Nov. 2020), pp.98-104, 7 p.

Publisher

The Arab Federation of Psychiatrists

Publication Date

2020-11-30

Country of Publication

Jordan

No. of Pages

7

Main Subjects

Psychiatry

Abstract EN

Obsessive-Compulsive Disorder (OCD) has moved from an anxiety disorder to a new distinct group of mental disorders.

The pharmacological basis for management of OCD is now better understood, and the guidelines for use of medication have proliferated in the past few years.

This article reviews the current recommendations and the basis for the use of medication for the treatment of OCD.

American Psychological Association (APA)

al-Tamimi, Sudad Jawad& Jamil, Nahlah Fawzi. 2020. Current pharmacological treatment of obsessive-compulsive disorder. The Arab Journal of Psychiatry،Vol. 31, no. 2, pp.98-104.
https://search.emarefa.net/detail/BIM-1268291

Modern Language Association (MLA)

al-Tamimi, Sudad Jawad& Jamil, Nahlah Fawzi. Current pharmacological treatment of obsessive-compulsive disorder. The Arab Journal of Psychiatry Vol. 31, no. 2 (Nov. 2020), pp.98-104.
https://search.emarefa.net/detail/BIM-1268291

American Medical Association (AMA)

al-Tamimi, Sudad Jawad& Jamil, Nahlah Fawzi. Current pharmacological treatment of obsessive-compulsive disorder. The Arab Journal of Psychiatry. 2020. Vol. 31, no. 2, pp.98-104.
https://search.emarefa.net/detail/BIM-1268291

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references : p. 102-104

Record ID

BIM-1268291